+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Therapy Market Research Report by Cell Type (Differentiated Cell and Stem Cell), Therapy Type, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989916
  • Report
  • April 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Anterogen Co.,Ltd.
  • Celgene Corporation
  • Medipost Co., Ltd.
  • NuVasive, Inc
  • PHARMICELL Co., Ltd.
  • Smith & Nephew PLC
The Global Cell Therapy Market size was estimated at USD 5,458.66 million in 2021, USD 6,040.14 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.82% to reach USD 10,116.16 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cell Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Cell Type, the market was studied across Differentiated Cell and Stem Cell.
  • Based on Therapy Type, the market was studied across Allogenic Therapies and Autologous Therapies.
  • Based on Application, the market was studied across Autoimmune Diseases, Dermatology, Muscoskeletal Therapies, and Oncology.
  • Based on End-User, the market was studied across Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Research Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Therapy market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Therapy Market, including Anterogen Co.,Ltd., Astellas Pharma Inc., Castle Creek Biosciences, Inc., Celgene Corporation, FUJIFILM Holdings America Corporation, JCR Pharmaceuticals Co., Ltd., Lonza Group AG, Medipost Co., Ltd., Novartis AG, NuVasive, Inc, Pfizer Inc., PHARMICELL Co., Ltd., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., and Vericel Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cell Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Cell Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Therapy Market?
6. What is the market share of the leading vendors in the Global Cell Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Therapy Market?
Frequently Asked Questions about the Global Cell Therapy Market

What is the estimated value of the Global Cell Therapy Market?

The Global Cell Therapy Market was estimated to be valued at $5458.7 Million in 2021.

What is the growth rate of the Global Cell Therapy Market?

The growth rate of the Global Cell Therapy Market is 10.8%, with an estimated value of $10116.2 Million by 2027.

What is the forecasted size of the Global Cell Therapy Market?

The Global Cell Therapy Market is estimated to be worth $10116.2 Million by 2027.

Who are the key companies in the Global Cell Therapy Market?

Key companies in the Global Cell Therapy Market include Anterogen Co.,Ltd., Astellas Pharma Inc., Castle Creek Biosciences, Inc., Celgene Corporation, FUJIFILM Holdings America Corporation, JCR Pharmaceuticals Co., Ltd., Lonza Group AG, Medipost Co., Ltd. and NuVasive, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anterogen Co.,Ltd.
  • Celgene Corporation
  • Medipost Co., Ltd.
  • NuVasive, Inc
  • PHARMICELL Co., Ltd.
  • Smith & Nephew PLC

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of stem cell for treatment of Alzheimer’s disease
5.1.1.2. Improvements in cell therapy supply chain
5.1.1.3. Increasing cell research activities and increasing approvals
5.1.2. Restraints
5.1.2.1. Side effects related to the stem cell transplant
5.1.3. Opportunities
5.1.3.1. Advancements in chimeric antigen receptor T-cell (CAR-T) therapies for cancer treatments
5.1.3.2. Investment help fuel a surge in biotech innovation
5.1.3.3. Use of ESCs (embryonic stem cells) and iPSCs (Induced pluripotent stem cells) to replace lost retinal cells
5.1.4. Challenges
5.1.4.1. Several ethical issues associated with the use of stem cells
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell
7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies
8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Muscoskeletal Therapies
8.5. Oncology
9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes
10. Americas Cell Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cell Therapy Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Anterogen Co.,Ltd.
14.2. Astellas Pharma Inc.
14.3. Castle Creek Biosciences, Inc.
14.4. Celgene Corporation
14.5. FUJIFILM Holdings America Corporation
14.6. JCR Pharmaceuticals Co., Ltd.
14.7. Lonza Group AG
14.8. Medipost Co., Ltd.
14.9. Novartis AG
14.10. NuVasive, Inc
14.11. Pfizer Inc.
14.12. PHARMICELL Co., Ltd.
14.13. Sartorius AG
14.14. Smith & Nephew PLC
14.15. Stemedica Cell Technologies, Inc.
14.16. Takeda Pharmaceutical Company Limited
14.17. Thermo Fisher Scientific Inc.
14.18. Vericel Corporation
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CELL THERAPY MARKET: DYNAMICS
FIGURE 2. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2027
FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2027
FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2027
FIGURE 19. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 28. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2027
FIGURE 30. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. AMERICAS CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. ARGENTINA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. BRAZIL CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. CANADA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. MEXICO CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. ASIA-PACIFIC CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. AUSTRALIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. CHINA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. INDIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. INDONESIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. JAPAN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. MALAYSIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. PHILIPPINES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SINGAPORE CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SOUTH KOREA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. TAIWAN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. THAILAND CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. FRANCE CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. GERMANY CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. ITALY CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. NETHERLANDS CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. QATAR CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. RUSSIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SAUDI ARABIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SOUTH AFRICA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SPAIN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED KINGDOM CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL CELL THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL THERAPY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CELL THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CELL THERAPY MARKET SIZE, BY STEM CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELL, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY STEM CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY STEM CELL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. ARGENTINA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. CANADA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. MEXICO CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. AUSTRALIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. CHINA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. INDIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. INDONESIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. JAPAN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. MALAYSIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. PHILIPPINES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. SINGAPORE CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. SOUTH KOREA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. TAIWAN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. THAILAND CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. FRANCE CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. GERMANY CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. ITALY CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. NETHERLANDS CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. QATAR CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. RUSSIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. SAUDI ARABIA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. SOUTH AFRICA CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. SPAIN CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. UNITED KINGDOM CELL THERAPY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. GLOBAL CELL THERAPY MARKET: SCORES
TABLE 93. GLOBAL CELL THERAPY MARKET: BUSINESS STRATEGY
TABLE 94. GLOBAL CELL THERAPY MARKET: PRODUCT SATISFACTION
TABLE 95. GLOBAL CELL THERAPY MARKET: RANKING
TABLE 96. GLOBAL CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 97. GLOBAL CELL THERAPY MARKET: MERGER & ACQUISITION
TABLE 98. GLOBAL CELL THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 99. GLOBAL CELL THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 100. GLOBAL CELL THERAPY MARKET: INVESTMENT & FUNDING
TABLE 101. GLOBAL CELL THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 102. GLOBAL CELL THERAPY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Anterogen Co.,Ltd.
  • Astellas Pharma Inc.
  • Castle Creek Biosciences, Inc.
  • Celgene Corporation
  • FUJIFILM Holdings America Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group AG
  • Medipost Co., Ltd.
  • Novartis AG
  • NuVasive, Inc
  • Pfizer Inc.
  • PHARMICELL Co., Ltd.
  • Sartorius AG
  • Smith & Nephew PLC
  • Stemedica Cell Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Vericel Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...